You are here: Home » Reuters » News
Business Standard

Analysis: $11 billion biotech binge fuels forecasts of 2018 M&A surge

Reuters  |  LONDON 

By Ben HirschlerLONDON (Reuters) - An $11 billion burst of biotech bids in just four days has fuelled expectations of a 2018 surge in life science deals as large drugmakers shop for promising assets from smaller rivals.Separate reports on Monday by consultancy EY and law firm Baker McKenzie both predict a significant rise in mergers and acquisitions (M&A) this year, helped by U.S. tax changes that may lift big companies' appetite for deals.Celgene's up to $7 billion agreed takeover of Impact Biomedicines, Novo Nordisk's $3.1 billion offer for Ablynx and Takeda Pharmaceutical's plan to buy ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, January 08 2018. 21:07 IST